| S0820, Adenoma and Second Primary Prevention Trial |
Eflornithine placebo & sulindac, Eflornithine placebo & sulindac placebo, Eflornithine plus sulindac, eflornithine & sulindac placebo |
Active, not recruiting |
| Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy |
|
Enrolling by invitation |
| Computer Training Program for Younger Patients With a Brain Tumor Who Underwent Radiation Therapy |
Cognitive Assessment, Computer-Assisted Cognitive Training, Psychosocial Assessment and Care, Quality-of-Life Assessment, Questionnaire Administration |
Active, not recruiting |
| Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission |
Behavioral Intervention, Compliance Monitoring, Laboratory Biomarker Analysis, Mercaptopurine, Questionnaire Administration, Standard Follow-Up Care |
Active, not recruiting |
| Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer |
Conization, Quality-of-Life Assessment, Questionnaire Administration, Therapeutic Conventional Surgery, Therapeutic Lymphadenectomy |
Active, not recruiting |
| Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment |
Assessment of Therapy Complications, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Questionnaire Administration |
Recruiting |
| Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas |
Laboratory Biomarker Analysis, Questionnaire Administration |
Active, not recruiting |
| MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer |
Breast surgery, Magnetic resonance imaging, Mammography |
Active, not recruiting |
| Reproductive Health Program in Patients With Cancer |
Standard practice related to reproductive heath, Training modules, algorithm, referral development |
Active, not recruiting |
| A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS) |
anastrozole, questionnaire administration, laboratory biomarker analysis, pharmacogenomic studies |
Active, not recruiting |